Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
37.45
-0.17 (-0.45%)
Official Closing Price
Updated: 7:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
24,222,755
Open
37.54
Bid (Size)
37.47 (100)
Ask (Size)
37.49 (1,800)
Prev. Close
37.62
Today's Range
37.33 - 37.86
52wk Range
37.31 - 91.90
Shares Outstanding
N/A
Dividend Yield
3.12%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MarketBeat Week in Review – 02/23 - 02/27
↗
Today 7:00 EST
Sometimes the best offense is a good defense. That’s what investors seem to be feeling. Technology stocks continue to be under pressure, and that money is flowing into traditionally defensive assets...
Via
MarketBeat
The Great Divergence: AI Supremacy Masks a Hidden Bear Market in Healthcare and Industrials
February 27, 2026
The final trading week of February 2026 has laid bare a striking fracture in the U.S. equity markets. While the technology sector continues to feast on a relentless AI-driven "execution" cycle, the...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Performance
YTD
-28.5%
-28.5%
1 Month
-37.9%
-37.9%
3 Month
-24.1%
-24.1%
6 Month
-33.7%
-33.7%
1 Year
-58.0%
-58.0%
More News
Read More
The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
February 27, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Got $5,000? Hims & Hers Could Be a Direct‑to‑Consumer Health Moonshot in the Making
↗
February 27, 2026
Via
The Motley Fool
Forget Altimmune: This Proven Obesity‑Drug Giant Is the Better Weight‑Loss Play
↗
February 26, 2026
Via
The Motley Fool
Why Shares of Novo Nordisk Stock Sank (Again) This Week
↗
February 26, 2026
Via
The Motley Fool
Viking Therapeutics: The High-Stakes Weight Loss Contender
↗
February 26, 2026
Via
MarketBeat
The Darwinian Transition: AI Monetization and Metabolic Mastery Define the Market’s New Frontier
February 26, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Hims & Hers at the Crossroads: Navigating the ‘Regulatory Winter’ of 2026
February 26, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore
↗
February 26, 2026
Via
The Motley Fool
Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies
↗
February 25, 2026
Via
The Motley Fool
Topics
Stocks
Eli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know.
↗
February 25, 2026
Via
The Motley Fool
1 Reason Why I'd Hold This Weight‑Loss Drug Leader Through Any Market Crash
↗
February 25, 2026
Via
The Motley Fool
Topics
Economy
NVO Investors Have Opportunity to Join Novo Nordisk A/S Fraud Investigation with the Schall Law Firm
February 25, 2026
From
Schall Law
Via
GlobeNewswire
Novo, Vivtex Ink $2.1 Billion Deal To Develop Oral Medicines For Obesity And Diabetes
↗
February 25, 2026
Via
Stocktwits
Novo Nordisk To Slash GLP-1 Drug Prices By Up To 50% In US Starting 2027
↗
February 25, 2026
Via
Benzinga
Could Novo Nordisk Help Turn $100,000 Into $1 Million in the GLP‑1 Gold Rush?
↗
February 25, 2026
Via
The Motley Fool
Why Eli Lilly Stock Slumped Today
↗
February 24, 2026
Via
The Motley Fool
Novo's 'Flashy' Ozempic, Wegovy Price Cuts Unlikely To Impact LLY Stock, Says BofA
↗
February 24, 2026
Via
Stocktwits
Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%: Report
↗
February 24, 2026
Via
Stocktwits
Topics
Artificial Intelligence
NVO Stock Continues To Decline Pre-Market After Monday’s Crash Amid CagriSema Setback – But Tuesday Brings Some Hope From China
↗
February 24, 2026
Via
Stocktwits
Got $5,000? Viking Therapeutics Might Be a Weight‑Loss Drug Moon Shot in the Making.
↗
February 23, 2026
Via
The Motley Fool
Stock Market Today, Feb. 23: Novo Nordisk Plunges 16% After Obesity Drug Falls Short
↗
February 23, 2026
Via
The Motley Fool
Topics
Stocks
Stock Market Today, Feb. 23: Nvidia Earnings Loom as Tariff Concerns Drive Dow 800 Points Lower
↗
February 23, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Stocks
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 37.45
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 02/27/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.